Apobiologix focuses on the marketing of biosimilars. The biosimilars program ofApobiologix is a natural extension of theApotexs long history of promoting access to affordable, high-quality medicines in Canada and around the world.
We aspire to transform access to affordable treatments through innovation, development and partnerships, in oncology as in other fields. At Apobiologixat Apobiologix, we believe that invention is not the only form of innovation; we believe that healthcare professionals and patients deserve access to affordable treatments that are uncompromising in terms of efficacy, quality and safety.
The company Apobiologix is a pioneer and leader in the field of oncology biosimilars in Canada.
AQCAMO aims to improve the lives of cancer patients. To this end, we are dedicated to facilitating access to oncology drugs for patients. With the help of our coordinators, we support and help patients and their families to free themselves as much as possible from the financial burden of medication.
To this end, we help patients and their families to research, complete and submit their applications to the appropriate financial aid and support programs. What’s more, we’re committed to knowledge sharing, and offer training and networking opportunities to all our access coordinators to exchange and share the latest knowledge in oncology drug access.
For further information, please contact our project manager at [email protected].